Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies

被引:24
作者
Masuda, Sonoko [1 ]
Prosser, David E. [1 ]
Guo, Yu-Ding [1 ]
Kaufmann, Martin [1 ]
Jones, Glenville [1 ]
机构
[1] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
基金
加拿大健康研究院;
关键词
vitamin D; calcitriol; cytochrome P450; CYP24A1; homology modeling; 1; alpha; 25(OH)(2)D-3; mutagenesis; vitamin D dependent-gene expression; vitamin D analogs; inhibitors;
D O I
10.1016/j.abb.2006.11.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A systematic analysis of conserved H-bonding patterns and tertiary structural motifs from 13 crystal structures was used to create a homology model for the human multicatalytic cytochrome P450, CYP24A1, involved in catabolism of 1 alpha,25-dihydroxyvitamin D-3. The substrate was docked in the active site and used to identify potential substrate contact residues in the B' helix, B'/C loop, F-helix and the beta-5 hairpin. Seven CYP24A1 mutants were created and studied by mammalian cell transfection and CYP24A1 activity assay. Mutants showed reduced metabolic rates and altered metabolite patterns compared to wild-type. We conclude that: Ile-131 positions substrate via A-ring and cis-triene contacts; Trp-134 and Gly-499 are determinants of substrate access; Leu-148 contacts the substrate side-chain; Met-246 is important in mediating regioselectivity. Our findings validate the new model of CYP24A1, which can now be used to predict structural modifications for rational vitamin D drug design. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:177 / 191
页数:15
相关论文
共 48 条
[11]   Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation [J].
He, XY ;
Shen, J ;
Hu, WY ;
Ding, XX ;
Lu, AYH ;
Hong, JY .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 427 (02) :143-153
[12]   Functional role of residues in the helix B′ region of cytochrome P4502B1 [J].
Honma, W ;
Li, WH ;
Liu, H ;
Scott, EE ;
Halpert, JR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 435 (01) :157-165
[13]   Current understanding of the molecular actions of vitamin D [J].
Jones, G ;
Strugnell, SA ;
DeLuca, HF .
PHYSIOLOGICAL REVIEWS, 1998, 78 (04) :1193-1231
[14]   MODELING PROTEIN SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450(BM-3) [J].
LI, HY ;
POULOS, TL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1995, 51 :21-32
[15]  
MARKIN G, 1989, BIOCHEM J, V262, P172
[16]   Distinct binding of cholesterol and 5-cholestane-3α,7α,12α-triol to cytochrome P450 27A1:: Evidence from modeling and site-directed mutagenesis studies [J].
Mast, N ;
Murtazina, D ;
Liu, H ;
Graham, SE ;
Bjorkhem, I ;
Halpert, JR ;
Peterson, J ;
Pikuleva, IA .
BIOCHEMISTRY, 2006, 45 (14) :4396-4404
[17]   Roles of phenylalanine at position 120 and glutamic acid at position 222 in the oxidation of chiral substrates by cytochrome P450 2D6 [J].
Masuda, K ;
Tamagake, K ;
Katsu, T ;
Torigoe, F ;
Saito, K ;
Hanioka, N ;
Yamano, S ;
Yamamoto, S ;
Narimatsu, S .
CHIRALITY, 2006, 18 (03) :167-176
[18]   Promise of vitamin D analogues in the treatment of hyperproliferative conditions [J].
Masuda, S ;
Jones, G .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (04) :797-808
[19]   Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse [J].
Masuda, S ;
Byford, V ;
Arabian, A ;
Sakai, Y ;
Demay, MB ;
St-Arnaud, R ;
Jones, G .
ENDOCRINOLOGY, 2005, 146 (02) :825-834
[20]   Insights into vitamin D metabolism using cyp24 over-expression and knockout systems in conjunction with liquid chromatography/mass spectrometry (LC/MS) [J].
Masuda, S ;
Kaufmann, M ;
Byford, V ;
Gao, M ;
St-Arnaud, R ;
Arabian, A ;
Makin, HLJ ;
Knutson, JC ;
Strugnell, S ;
Jones, G .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :149-153